Bullfrog AI Holdings, Inc. BFRG 深 沪
等待开盘 09-16 09:30:00 美东时间
1.405
+0.078
+5.88%
华盛通- 最 高1.43
- 今 开1.34
- 成交量 15.20万股
- 最 低 1.3104
- 昨 收 1.327
- 总市值 1416.42万
- 52周最高 4.84
- 市盈率 静 --
- 换手率 1.51%
- 52周最低 1.09
- 委 比 4.71%
- 总股本 1008.13万
- 历史最高 9.50
- 量 比 1.18
- 振 幅 9.01%
- 历史最低 1.09
- 每 手 1
- 风险率 0.53%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多BullFrog AI’s bfPREP™ and bfLEAP® Platforms Deliver Real-World Impact in Eleison Pharmaceuticals Collaboration
BullFrog AI collaborates with Eleison Pharmaceuticals to advance oncology treatments, developing a new data ingestion module, bfPREP™, which successfully processed over 10,000 clinical trial PDFs into a standardized dataset. Leveraging its AI platform, BullFrog enhanced data analysis, identifying patient subgroups for optimized trial design and market positioning. The companies are preparing a joint conference submission and exploring further col...
09-08 12:00
BullFrog AI Faces Nasdaq Non-Compliance Notice
BullFrog AI Holdings, Inc. ( ($BFRG) ) just unveiled an announcement. On August...
08-28 05:01
Bullfrog AI Hldgs Q2 EPS $(0.15) Up From $(0.20) YoY, Sales $33.257K
Bullfrog AI Hldgs (NASDAQ:BFRG) reported quarterly losses of $(0.15) per share. This is a 25 percent increase over losses of $(0.20) per share from the same period last year. The company reported $33.257 thousand in
08-14 05:49
BullFrog AI to Present at BTIG Annual Virtual Biotechnology Conference
BullFrog AI Holdings, Inc. CEO Vin Singh will participate in a fireside chat and one-on-one meetings at BTIG’s Annual Virtual Biotechnology Conference on July 30, 2025, at 11:20 a.m. ET. The company leverages AI and machine learning to advance drug discovery and reduce clinical trial failures. For more information, contact BFRG@redchip.com.
07-28 20:30
Rethinking R&D: BullFrog AI White Paper Outlines New Blueprint for Smarter Drug Development
BullFrog AI introduces its proprietary bfLEAP™ platform, designed to address challenges in biopharma R&D by leveraging biologically grounded AI. The platform, derived from Johns Hopkins technology, enhances therapeutic success through actionable insights at every drug development stage. Unlike generic AI models, bfLEAP™ handles complex biomedical data and compositional variables, addressing issues that cause 90% of drug candidates to fail in tria...
07-22 12:00
Join BullFrog AI’s Exclusive Live Investor Webinar and Q&A Session on July 23
BullFrog AI Holding,一家利用人工智能（AI）和机器学习技术推动药物开发的公司，将于7月23日举办网络研讨会，介绍其AI驱动平台，包括新模块bfPREP™，以及与Sygnature Discovery的合作，并探讨其在全球生物制药研发市场中的增长潜力。活动免费，注册及问题提交可通过提供的链接完成。
07-18 13:00
BullFrog AI Launches bfPREP, a New AI-Powered Data Preparation Module in Its BullFrog Data Networks Solutions Library
BullFrog AI introduces bfPREP™, a new module addressing the multi-billion-dollar data quality challenge in life sciences by automating data cleansing, standardization, and transformation for AI readiness. Designed for scale, security, and human expertise, bfPREP™ transforms raw clinical, omics, and real-world data into analysis-ready insights, enabling faster AI workflows. With its proprietary algorithms and unique features like biomedical intell...
07-17 12:00
BullFrog AI Unveils BullFrog Data Networks™ Solutions Library, Expanding Scalable AI-Powered Biomedical Insight Platform to Large Enterprises
BullFrog AI Holdings, Inc. launched its new BullFrog Data Networks™ Solutions Library, a cloud-native AI-powered platform supporting Google Cloud, Microsoft Azure, and AWS. Designed for large biopharma organizations, the platform offers scalable, secure solutions for drug discovery and development through specialized modular components. Its cloud partnerships ensure high performance, compliance, and flexibility across hybrid environments. The pla...
07-10 12:00
BullFrog AI’s Dr. Juan Felipe Beltrán to Highlight Advanced AI Strategies in Bioinformatics at XTalks Webinar
GAITHERSBURG, Md., June 20, 2025 (GLOBE NEWSWIRE) – BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) announced that Dr. Juan Felipe Beltrán, Director of AI, Machine Learning, and Innovation, will speak at the XTalks webinar "AI in Bioinformatics: Overcoming Pitfalls in Statistical, ML, and Generative AI Approaches." Dr. Beltrán will discuss critical challenges in AI-driven bioinformatics, including mismanagement of compositional data, overinterpr...
06-20 12:00
BullFrog AI Announces Strategic Collaboration With Sygnature Discovery To Expand AI Platform Reach, Projecting Up To $30M Revenue By 2028
BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW))) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful
06-12 20:09
